GILD

Gilead Sciences, Inc. News Headlines

$91.53
*  
1.69
1.88%
Get GILD Alerts
*Delayed - data as of Jul. 28, 2014 14:34 ET  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Hepatitis C Remains A Hot Play
2/27/2012 4:06:00 AM - Seeking Alpha

Top Q4 Undervalued Buys And Sells Of Stephen Cohen's $15.8 Billion Hedge Fund
2/27/2012 2:58:00 AM - Seeking Alpha

Insider Buys And Sells: Dell, IBM
2/26/2012 4:36:00 AM - Seeking Alpha

Noteworthy Insider Buys And Sells In Healthcare On Wednesday To Friday
2/26/2012 4:10:00 AM - Seeking Alpha

Recent Performance Review For 7 Biotech Equities
2/24/2012 10:57:00 AM - Seeking Alpha

How Best To Profit From Stock Spin-Offs
2/23/2012 12:36:00 PM - Seeking Alpha

A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell
2/22/2012 9:02:00 AM - Seeking Alpha

5 Misunderstood Stocks With Up To 42% Upside
2/21/2012 7:59:00 AM - Seeking Alpha

Friday's Overreaction Provides Great Entry Point For Gilead
2/21/2012 4:11:00 AM - Seeking Alpha

After Gilead's Drop: Hedging 5 Biotechnology Stocks
2/20/2012 5:08:00 AM - Seeking Alpha

Top Q4 Undervalued Buys And Sells From Hedge Fund Farallon Capital Management
2/19/2012 9:11:00 AM - Seeking Alpha

Why I Picked Up Endo Pharmaceuticals At Under $35
2/19/2012 1:43:00 AM - Seeking Alpha

Gilead's Electron Data Brings Some Reality Back To The Hep C Market
2/17/2012 9:03:00 AM - Seeking Alpha

John Paulson Continues Massive 'De-Risking' In Q4
2/16/2012 10:02:00 AM - Seeking Alpha

Alexion Pharmaceuticals: A Tricky Mix Of Biotech And Pharma
2/14/2012 5:31:00 AM - Seeking Alpha

Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
2/14/2012 4:41:00 AM - Seeking Alpha

MFS Investment Management's Top Q4 Undervalued Buys And Sells
2/12/2012 3:03:00 AM - Seeking Alpha

Expecting Gilead To Break $70, Outperforming Merck
2/12/2012 2:25:00 AM - Seeking Alpha

Analyzing Thursday's Noteworthy Insider Buys And Sells In Healthcare And Tech Sectors
2/10/2012 2:27:00 PM - Seeking Alpha

Hedging 8 Debt-Free, Undervalued Market-Beating Stocks
2/7/2012 7:41:00 PM - Seeking Alpha

Trading Biotech In Pairs: A Better Way To Hedge
2/7/2012 10:06:00 AM - Seeking Alpha

Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management
2/7/2012 2:36:00 AM - Seeking Alpha

4 Biotech Stocks To Buy, 1 To Avoid For Now
2/6/2012 4:29:00 PM - Seeking Alpha

5 Buying Opportunities Based On Fundamentals, Profitability And Dividends
2/6/2012 4:04:00 PM - Seeking Alpha

Biopharma Report Card: 2-Week Checkup
2/6/2012 11:16:00 AM - Seeking Alpha